Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEland Oil & Gas Regulatory News (ELA)

  • There is currently no data for ELA

Operations Update

14 Aug 2013 07:00

RNS Number : 6219L
Eland Oil & Gas PLC
14 August 2013
 



 

14 August 2013

 

ELAND OIL & GAS PLC

 

("Eland" or the "Company")

 

Operations Update

 

Eland Oil & Gas PLC (AIM: ELA), an oil & gas development and exploration company operating in West Africa with a principal focus on Nigeria, announces the following update on activities for the OML 40 License, located in on shore Nigeria ("OML 40").

 

Highlights

 

Once first oil is achieved, the long term development and appraisal drilling programme for OML 40 will commence with the Opuama Field which has certified gross 2P reserves of 54 Million bbls (from a total licence 2P number of 82 Million) and an initial production capacity of 30,000 bopd.

 

· Refurbishment of existing facilities is now progressing with operations personnel on site and initial integrity tests indicating that the facilities are in good condition

 

· Some delays in contracting services and local permitting have been experienced to date and as a result first oil production in excess of 2,500 bopd from two previously shut in wells is now anticipated in October

 

· The Swamp Rig 'Depthwize Imperial' is planned to mobilize to OML 40 in Q4 2013 allowing the commencement of drilling the first new well before year end. Contractual arrangements are currently being finalized by the operator, NPDC

 

· Year end exit production rate is anticipated in the range 2,500 to 5,500 bopd, dependent on timing of completion of the first new well. It is expected that production will increase by circa 3,000 bopd for each subsequent new well drilled

 

· Debt facilities already agreed are available post first oil.

 

 

OML 40 Operations update

 

Since the Company's previous operations update, contained in the 2012 Annual Results published on 29 May 2013, planning and work for the rehabilitation and restart of existing production facilities on OML 40 has continued.

 

NPDC's refurbishment and recertification of the existing production flowstation facilities and the 30 metre sectional repair of the export pipeline is on-going. Integrity tests have been made on the facilities and all are in good condition with a minimum level of refurbishment needed. Two new 4" flowlines are being installed to replace the pre-exiting lines as a precautionary measure against corrosion.

 

Initial production will be from two existing wells that were shut in in 2006 in a controlled shutdown. These wells are anticipated to flow at a minimum rate of 2,500 bopd based on the well test conducted immediately prior to the controlled shutdown with additional development wells forecast to flow at 3,000 bopd. With this work still underway, production restart on OML 40 is expected for October.

 

Following the restoration of production, the development drilling programme will start on the Opuama field where there are production and export facilities with a throughput capacity of 30,000 bopd and where Netherland, Sewell & Associates, Inc. recently certified gross 2P reserves of 54.2 MMbbls.

 

Initial drilling will be performed by the swamp rig 'Imperial', which will be secured by NPDC and committed to the development programme on OML 40 in Q4 2013. It is planned that the Imperial will move across to OML 40 later in the year, when it's current operator completes a single well program.

 

Previous guidance for drilling has been 2 production wells to spud in 2013 with a year end exit production rate of 10,000 bopd. Due to a delay in rig availability the Company is adjusting its guidance to one new development well being spudded in Q4 2013 with an exit production rate in the range of 2,500 and 5,500 bopd, dependent on timing of completion of the first new well. The spudding of the second development well on Opuama field, planned and budgeted for 2013, is now anticipated for early 2014 in conjunction with the on-going field development plan.

 

 

 

Les Blair, CEO of Eland Oil & Gas, commented:

 

"Field refurbishment is progressing well and despite earlier delays, indications are that the facilities are in good condition which bodes well for the long-term development of OML 40. We are looking forward to gaining entry to the two previously shut in wells and our first production revenues.

 

Furthermore, we are very excited at the prospect of drilling of our first new production well and subsequently beginning the process of rapid production growth, at what we anticipate to be a rate of circa 3,000 bopd for each scheduled new well.

 

The momentum of OML 40 development work is now gathering pace."

 

 

 

For further information:

 

Eland Oil & Gas PLC (+44 (0) 207 016 3180)

Les Blair, CEO

George Maxwell, CFO

Edward Cozens, IR

 

Canaccord Genuity Limited (+44 (0) 207 523 8000)

Henry Fitzgerald-O'Connor

Peter Stewart

 

FirstEnergy Capital LLP (+44 (0) 207 448 0200)

Majid Shafiq

Khalid Ahmed

 

Citigate Dewe Rogerson (+44 (0) 207 638 9571)

Martin Jackson

Jack Rich

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBUGDIBUBBGXX
Date   Source Headline
17th Jul 20095:57 pmBUSStudies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease
16th Jul 20092:18 pmRNSResults of Annual General Meeting
13th Jul 200911:30 amBUSElan and Transition Therapeutics Announce Phase 1 Data Showing ELND005 Achieves Desired Concentrations in Brain Tissue and Cerebrospinal Fluid
10th Jul 20094:59 pmRNSCancellation of UK Listing
8th Jul 20097:00 amBUSElan Announces Webcast of Second Quarter 2009 Financial Results
3rd Jul 200910:57 amRNSBlock Listing Six Monthly Return
2nd Jul 200912:57 pmRNSHolding in Company
2nd Jul 200912:41 pmPRNJohnson & Johnson, Elan Announce Definitive Agreement
1st Jun 20097:00 amBUSSubset Data from Two Randomized Phase 3 Trials Show TYSABRI® Significantly Improves Health-Related Quality of Life for Crohn's Disease Patients with Prior Exposure or Inadequate Response to Anti-TNF? Therapy
29th May 20094:36 pmRNSPrice Monitoring Extension
29th May 20092:00 pmBUSRenee P. Tannenbaum, Pharm.D. Joins Elan as Executive Vice President and Chief Commercial Officer
29th May 200911:54 amBUSTotal Voting Rights
30th Apr 200912:16 pmBUSTotal Voting Rights
27th Apr 20093:35 pmRNSAnnual Report
14th Apr 20095:09 pmRNSHolding(s) in Company
27th Feb 20092:44 pmBUSTotal Voting Rights
25th Feb 200912:23 pmBUSDirector/PDMR Shareholding
12th Feb 20096:00 pmBUSDirector/PDMR Shareholding
12th Feb 20096:00 pmBUSDirector/PDMR Shareholding
9th Feb 20097:00 amBUSMS Patients Treated with TYSABRI® Remain Free of Disease Activity for Two Years, According to Data Published in the Lancet Neurology
4th Feb 20092:32 pmRNSHolding(s) in Company
3rd Feb 20093:57 pmRNSHolding(s) in Company
30th Jan 20094:33 pmRNSHolding(s) in Company
28th Jan 20094:24 pmRNSHolding(s) in Company
13th Jan 20097:00 amBUSElan Clarifies Duration of Bapineuzumab Phase 3 Trials
12th Jan 20095:21 pmRNSHolding(s) in Company
12th Jan 20097:00 amBUSTysabri Update
2nd Jan 200912:21 pmRNSTotal Voting Rights
18th Dec 20084:24 pmRNSBlock Listing Six Monthly Return
16th Dec 200811:00 amBUSDirector Declaration
16th Dec 20087:00 amBUSElan to Present at the 27th Annual JP Morgan Healthcare Conference
15th Dec 20083:02 pmBUSTysabri Update
12th Dec 20087:00 amBUSElan Announces Resource Realignment
28th Nov 200810:47 amBUSTotal Voting Rights
25th Nov 20087:00 amBUSMary Stutts to Join Elan as Senior Vice President and Head of Corporate Relations
20th Nov 20087:00 amBUSCarlos V. Paya, MD, PhD, to Join Elan as Company President
3rd Nov 20085:12 pmRNSDirector/PDMR Shareholding
31st Oct 20084:11 pmRNSHolding in Company
31st Oct 200812:01 pmRNSTotal Voting Rights
30th Oct 20084:13 pmRNSTysabri Update
3rd Oct 20085:56 pmRNSHolding in Company
30th Sep 20084:11 pmRNSTotal Voting Rights
22nd Sep 200811:26 amRNSHolding In Company
22nd Sep 20087:00 amRNSTysabri Demonstrates Sustained Improvement
11th Sep 20087:39 amRNSDirector /PDMR Shareholding
1st Sep 20085:02 pmRNSHolding(s) in Company
29th Aug 200810:54 amRNSTotal Voting Rights
28th Aug 20087:00 amRNSInterim Results
14th Aug 20084:12 pmRNSHolding in Company
13th Aug 20085:22 pmRNSHolding in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.